Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Hyperscale Data stock jumps 23% premarket amid Bitcoin treasury growth and market optimism

Market News
08 Jun 2026
Lekha Gupta
View Source
Neutral
pluang ai news

Hyperscale Data's stock surged 23.18% in premarket trading driven by a broader market rally and increased risk appetite among investors. The company reported holding 704.34 Bitcoin, valued at about $51.8 million as of May 31, 2026, reinforcing its digital asset strategy. Despite this short-term gain, the stock remains down nearly 97% over the past year, with mixed technical signals indicating ongoing long-term challenges. Hyperscale plans to spin off its Ault Capital Group subsidiary in 2027 to focus on AI data centers and digital assets.

More News

Cyabra inks $500K+ deal to fight online hate with AI-powered disinformation detection for global research institute

Cyabra inks $500K+ deal to fight online hate with AI-powered disinformation detection for global research institute

Cyabra, an AI-driven disinformation intelligence company, has secured a contract worth over $500,000 to provide its technology to a leading international research institute focused on tracking global hate speech. The platform will help identify coord...

Market News
Bullish
16 minutes ago
Ormat launches Ormega100, the largest binary geothermal unit, to boost Enhanced Geothermal System deployment.

Ormat launches Ormega100, the largest binary geothermal unit, to boost Enhanced Geothermal System deployment.

Ormat Technologies introduced the Ormega100, the industry's largest binary power generation unit delivering 100 MW output, designed to accelerate commercialization and scaling of Enhanced Geothermal Systems (EGS). With 60 years of expertise and exten...

Market News
Bullish
16 minutes ago
Novo Nordisk's new diabetes drugs show strong weight loss and blood sugar control in trials.

Novo Nordisk's new diabetes drugs show strong weight loss and blood sugar control in trials.

Novo Nordisk announced positive Phase 3 trial results for CagriSema, a once-weekly therapy combining an amylin analog with a GLP-1 receptor agonist, which significantly reduced HbA1c and body weight in adults with Type 2 diabetes. The company also sh...

Company Fundamentals
Bullish
21 minutes ago
Ingredion to buy Tate & Lyle for $5B in cash, expanding its specialty ingredients portfolio.

Ingredion to buy Tate & Lyle for $5B in cash, expanding its specialty ingredients portfolio.

Ingredion announced an all-cash acquisition of Tate & Lyle for about $5 billion, offering Tate & Lyle shareholders a 59% premium per share. The deal broadens Ingredion's product range in texturants, sugar reduction, and recipe development, and is exp...

Company Fundamentals
Bullish
34 minutes ago
Deadlines set for lead plaintiff in class actions against Graphic Packaging, Immutep, and Phreesia investors.

Deadlines set for lead plaintiff in class actions against Graphic Packaging, Immutep, and Phreesia investors.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Graphic Packaging Holding Company, Immutep Limited, and Phreesia, Inc. These lawsuits allege misleading statements or no...

Market News
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App